Relative Contraindication to Endoscopic Subureteral Injection for Vesicoureteral Reflux: Congenital Refluxing Megaureter with Distal Aperistaltic Segment - 23/08/11
, Sameer A. Siddiqui b, Yuri Reinberg c, Laurence S. Baskin a
Reprint requests: David S. Aaronson, M.D., Department of Urology, University of California, San Francisco, Children’s Hospital, Ambulatory Care Center, Suite A633, San Francisco, CA 94117.Résumé |
Objectives |
Endoscopic subureteral injection for the management of vesicoureteral reflux has become a well-established first-line minimally invasive treatment strategy. One potential pitfall is the creation of ureteral obstruction. No predictors are available to determine which patients will develop this rare, but real, complication.
Methods |
A retrospective evaluation of 2 girls, aged 3 and 4 years, with grade 4 and 3 reflux, respectively, and documented ureteral obstruction after endoscopic treatment with dextranomer/hyaluronic acid copolymer. Before treatment, both patients had had refluxing megaureters with a distal aperistaltic segment.
Results |
Ultimately, they both required open, cross-trigonal ureteral reimplantation with resolution of vesicoureteral reflux and ureteral obstruction.
Conclusions |
Congenital refluxing megaureter with a distal aperistaltic segment might be a relative contraindication to endoscopic subureteral injection of a bulking agent for the management of vesicoureteral reflux.
Le texte complet de cet article est disponible en PDF.Plan
Vol 71 - N° 4
P. 616-619 - avril 2008 Retour au numéro
Article précédent
- Modified Tubularized Incised Plate Urethroplasty for Hypospadias Repair: A Long-Term Results of 764 Patients
- Abdel-Wahab El-Kassaby, Ahmed M. Al-Kandari, Tarek Elzayat, Ahmed A. Shokeir
- Editorial Comment
- Andrew J. Kirsch
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?